Affordable Access

deepdyve-link
Publisher Website

Antigen-specific versus antigen-nonspecific immunotherapeutic approaches for human melanoma: the need for integration for optimal efficacy?

Authors
Type
Published Article
Journal
International Reviews of Immunology
Publisher
Informa UK (Taylor & Francis)
Volume
30
Issue
5-6
Pages
238–238
Identifiers
DOI: 10.3109/08830185.2011.598977
Source
Murphy Lab dermatology-ucdavis
License
Unknown

Abstract

Due to its immunogenecity and evidence of immune responses resulting in tumor regression, metastatic melanoma has been the target for numerous immunotherapeutic approaches. Unfortunately, based on the clinical outcomes, even the successful induction of tumor-specific responses does not correlate with efficacy. Immunotherapies can be divided into antigen-specific approaches, which seek to induce T cells specific to one or several known tumor associated antigens (TAA), or with antigen-nonspecific approaches, which generally activate T cells to become nonspecifically lytic effectors. Here the authors critically review the different immunotherapeutic approaches in melanoma.

Report this publication

Statistics

Seen <100 times